Butterfly Network (BFLY) Stock Forecast & Price Target

Butterfly Network is well positioned because its cMUT-based iQ handheld platform offers whole-body imaging in a single probe at a lower cost than traditional ultrasound, supporting adoption across point-of-care settings and expanding its addressable market. The company’s Embedded strategy adds a second growth engine, with 12 partnerships, 11 Embedded partners exiting 2Q26, and 2Q26 revenue rising 39% to $32.6M while gross margin expanded 770 bps to 71.4%, reflecting high-margin licensing and technology access revenue. Looking ahead, the 1Q27 next-generation iQ launch, three Garden applications in 2H26, and management’s expectation of FCF breakeven in 2027 create multiple catalysts for operating leverage and a stronger balance sheet.

Butterfly Network is facing a bearish setup because its growth story depends heavily on Embedded partnerships that may take longer to commercialize, which could stall operating expense leverage and leave near-term revenue growth merely positive rather than strong. The company is also beginning to lap tougher comps in 2H26 and again from 4Q26 after the 4Q25 Midjourney milestone, raising the risk that any revenue disappointment could trigger multiple contraction as investors look for beats-and-raises. Longer-term value still rests on development progress and downstream optionality from deals like Merge, but the current risk profile is weighed down by commercialization uncertainty, customer concentration, manufacturing and pricing risks, and the possibility that profitability does not ramp as expected.